Skip to main content
. 2020 Aug 6;18:305. doi: 10.1186/s12967-020-02460-3

Fig. 3.

Fig. 3

TOX expression predicts better survival in glioma patients. Kaplan–Meier analysis of overall survival (OS), disease specific survival (DSS) and progressive free survival (PFS) based on high vs low expression of TOX in pan-glioma analysis, LGG alone, and GBM alone in the TCGA dataset. The median value of TOX expression was used as the cut-off value. P-values were obtained from the log-rank test